docetaxel anhydrous has been researched along with Leukemia, Myeloid in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chavez-MacGregor, M; Giordano, SH; Niu, J; Rosenstock, AS; Wolff, AC; Zhao, H | 1 |
| Griesinger, F; Haase, D; Metz, M; Schulz, T; Trümper, L | 1 |
| Adamson, PC; Franklin, JL; Fu, C; Krailo, M; Reaman, G; Seibel, NL | 1 |
| Kanamaru, R; Murata, K; Sato, T | 1 |
| Behm, FG; Campana, D; Consolini, R; Pui, CH; Raimondi, SC | 1 |
1 trial(s) available for docetaxel anhydrous and Leukemia, Myeloid
| Article | Year |
|---|---|
Phase 2 study of docetaxel in the treatment of childhood refractory acute leukemias: a Children's Oncology Group report.
Topics: Acute Disease; Adolescent; Adult; Antineoplastic Agents, Phytogenic; Bone Marrow Diseases; Child; Child, Preschool; Docetaxel; Drug Administration Schedule; Female; Fever; Humans; Infant; Infusions, Intravenous; Leukemia; Leukemia, Myeloid; Male; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Salvage Therapy; Taxoids; Treatment Failure | 2008 |
4 other study(ies) available for docetaxel anhydrous and Leukemia, Myeloid
| Article | Year |
|---|---|
Acute myeloid leukemia and myelodysplastic syndrome after adjuvant chemotherapy: A population-based study among older breast cancer patients.
Topics: Acute Disease; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bridged-Ring Compounds; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Female; Humans; Leukemia, Myeloid; Medicare; Myelodysplastic Syndromes; Neoplasm Staging; Registries; Risk Factors; SEER Program; Taxoids; Texas; United States | 2018 |
Secondary leukaemia after cure for locally advanced NSCLC: alkylating type secondary leukaemia after induction therapy with docetaxel and carboplatin for NSCLC IIIB.
Topics: Acute Disease; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chromosome Aberrations; Docetaxel; Humans; Karyotyping; Leukemia, Myeloid; Lung Neoplasms; Male; Myelodysplastic Syndromes; Neoplasms, Second Primary; Taxoids | 2004 |
[Effect of a new anticancer drug, docetaxel (RP56976), on human leukemia cell lines].
Topics: Antineoplastic Agents, Phytogenic; Cell Cycle; Cell Division; DNA Topoisomerases, Type I; Docetaxel; Doxorubicin; Drug Resistance; Humans; Leukemia, Myeloid; Paclitaxel; Taxoids; Tumor Cells, Cultured; Vincristine | 1994 |
In vitro cytotoxicity of docetaxel in childhood acute leukemias.
Topics: Acute Disease; Adolescent; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Survival; Child; Child, Preschool; Docetaxel; Drug Screening Assays, Antitumor; Drug Synergism; Flow Cytometry; Humans; Infant; Karyotyping; Leukemia, Myeloid; Paclitaxel; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Taxoids; Tumor Cells, Cultured; Vincristine | 1998 |